DUSA Pharmaceuticals

Last updated
DUSA Pharmaceuticals, Inc.
Company type Subsidiary
Industry Pharmaceuticals
Founded1991;34 years ago (1991)
FounderRick Lufkin
Defunct2012 (2012)
FateAcquired
SuccessorDUSA Dermatology
Headquarters
Billerica, MA
,
United States
Area served
United States
ProductsDermatological pharmaceuticals and treatments
Owner Sun Pharma
Website www.dusapharma.com www.levulanhcp.com

DUSA Pharmaceuticals was an American pharmaceutical company with dermatology products, including Levulan and Nicomide. It was acquired by Sun Pharma in 2012 and the brand continues as DUSA Dermatology within the Sun Pharma company.

Contents

History

In the first quarter of 2006, DUSA Pharmaceuticals obtained Sirius Laboratories in a merger estimated to be worth 30 million dollars. Sirius was a privately held dermatology specialty pharmaceuticals company founded by Dr. Joel E. Bernstein in 2000 dedicated to the treatment of acne vulgaris and acne rosacea. [1]

In 2012, Caraco Pharmaceutical Laboratories (CPL), a subsidiary of Sun Pharmaceutical, acquired DUSA. [2] [3]

References

  1. ↑ "DUSA Pharmaceuticals Closes Acquisition of Sirius Laboratories". BNET. 2006-04-14. Retrieved 2008-08-26.
  2. ↑ "Offer to purchase for cash all outstanding Shares of Common Stock of DUSA PHARMACEUTICALS, INC". US Securities and Exchange commission. December 19, 2012.
  3. ↑ "Caraco Pharmaceutical Laboratories Announces Successful Tender Offer To Acquire DUSA". December 20, 2012. Archived from the original on 2015-09-12.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.